The Board of Directors is responsible for defining Bachem’s corporate strategy and the members are elected by the company shareholders at the Annual General Meeting.
Peter Grogg († 02. June 2025)
Founder
Kuno Sommer
Chairman
Dr. Kuno Sommer, Ph.D. University of Basel, worked for Roche from 1986 to 1999 in various functions, including four years in the USA. Kuno Sommer was ultimately a member of the Executive Committee of Roche, responsible for the Flavours and Fragrances division, today Givaudan. From 2000 to 2006 he was CEO of Berna Biotech. Kuno Sommer is Chairman of the Board of Sunstar-Holding AG, of Kenta Biotech AG, of TargImmune Therapeutics AG and, until Septem-
ber 1, 2023, of Infors AG as well as member of the Board of Directors of Spexis AG..
Nicole Grogg Hötzer
Vice-Chairwoman
Nicole Grogg Hötzer graduated in Biology at Basel University in 1999. Afterwards, she worked in various positions in the field of regulatory affairs. In 2002 Nicole Grogg Hötzer began her postgraduate studies in Business Administration at the University of Applied Sciences Basel which she completed successfully in 2004. Nicole Grogg Hötzer is Chairwoman of the Board of Directors of MFC Beteiligungs AG as well as Vice-Chairwoman of the Board of Directors of Ingro Finanz AG, of Hotel Bad Schauenburg AG and of Sunstar-Holding AG.
Helma Wennemers
Member
Prof. Dr. Helma Wennemers graduated with a diploma degree in chemistry from Johann-Wolfgang-Goethe University in Frankfurt in 1993. Three years later she earned a doctorate degree from Columbia University, New York. She then pursued post-doctoral studies at Nagoya University before accepting the “Bachem-Stiftungs-Assistenzprofessur” at the University of Basel in 1999, where she became Associate Professor in 2003. Since 2011, she is Professor at the Laboratory of Organic Chemistry at ETH Zürich. Helma Wennemers’ research has been recognized by several awards, including the Leonidas Zervas Award from the European Peptide Society (2010), the Pedler Award from the Royal Society of Chemistry (2016), the Inhoffen Medal from the Helmholtz Center (2017), the Arthur C. Cope Scholar Award from the American Chemical Society (2021), the Scoffone Prize from the Italian Peptide Society (2022) and the “Vincent du Vigneaud Award” from the American Peptide Society (2023).
Steffen Lang
Member
Dr. Steffen Lang has been President of Novartis Operations since 2022. He is a member of the Executive Committee of Novartis. Prior to his current appointment, Steffen Lang served as Global Head Novartis Technical Operations from 2017 to 2022. He joined Novartis in 1994 as Head of Laboratory in Research, and over the years has held various positions within Pharmaceuticals Development and Technical Operations. Mr. Lang holds a doctorate in pharmaceutical technology from the Swiss Federal Institute of Technology (ETHZ), and a degree in pharmaceutical sciences from the University of Heidelberg in Germany.
Alex Fässler
Member
Dr. Alex Fässler began his industrial career at Ciba-Geigy, later Novartis, where he held various positions in preclinical Research in Basel, New Jersey and England. He joined Bachem AG in 1998, and thereafter served as Head of Production in the US subsidiary, site manager and finally as regional COO for the Americas. After his return to Switzerland in 2013 he was appointed COO of Bachem Europe, and from 2017 to 2018 he held the function of COO of the Bachem Group, and was a member of the Corporate Executive Committee.
Simone Wyss Fedele
Member
Dr. Simone Wyss Fedele has been CEO of Switzerland Global Enterprise (S-GE), the official Swiss organization for export and investment promotion, since 2019, where she intermittently also held the role of CFO. She is designated for the chairmanship of the S-GE Board of Directors and is currently a member of the WEF Global Future Councils on International Trade and Investment. Before, she was Chief Economist and Head of Public Affairs at Novartis International in Switzerland. Prior to that, she was Commercial Lead and Head of Market Access for Europe and Canada at Takeda Pharmaceuticals. She holds a doctorate in international economics from the University of Basel.
Corporate Executive Committee
Responsible for managing Bachem and for implementing policies and strategies as defined by the Board of Directors.
Click here >>